MiR‐497‐5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin‐like growth factor 1

Autor: Hai-Jian Zou, Zhi-Ping Huang, F. Charles Brunicardi, Jia Fu, Chao Song, Guo-Shu Xu, Zi-Wei Li, Rui-Fen Sun
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
medicine.medical_treatment
Apoptosis
030105 genetics & heredity
medicine.disease_cause
Metastasis
Mice
Cell Movement
Insulin-Like Growth Factor I
Neoplasm Metastasis
3' Untranslated Regions
Genetics (clinical)
Liver Neoplasms
IGF1
hepatocellular carcinoma
Middle Aged
Prognosis
3. Good health
Hepatocellular carcinoma
biomarker
Original Article
Female
Carcinoma
Hepatocellular

lcsh:QH426-470
proliferation
Down-Regulation
Mice
Nude

03 medical and health sciences
Downregulation and upregulation
miR‐497‐5p
Cell Line
Tumor

microRNA
Genetics
medicine
Animals
Humans
Molecular Biology
neoplasms
Cell Proliferation
Cell growth
business.industry
Growth factor
Cancer
Antagomirs
Original Articles
medicine.disease
digestive system diseases
MicroRNAs
lcsh:Genetics
030104 developmental biology
Cancer research
Carcinogenesis
business
Zdroj: Molecular Genetics & Genomic Medicine, Vol 7, Iss 10, Pp n/a-n/a (2019)
Molecular Genetics & Genomic Medicine
ISSN: 2324-9269
Popis: Background MicroRNAs (miRNAs) play an important regulatory role in carcinogenesis and cancer progression. Aberrant expression of miR‐497‐5p has been reported in various human malignancies. However, the role of miR‐497‐5p in hepatocellular carcinoma (HCC) remains unclear. Results In this study, we found that miR‐497‐5p was downregulated in HCC tissues. The low level of miR‐497‐5p in HCC tumors was correlated with aggressive clinicopathological characteristics and predicted poor prognosis in HCC patients. The overexpression of miR‐497‐5p significantly inhibited HCC cell proliferation, colony formation, and metastasis in vitro and vivo. Bioinformatics analysis further identified insulin‐like growth factor 1 (IGF1) as a novel target of miR‐497‐5p in HCC cells. Conclusion Our study suggested that miR‐497‐5p regulates HCC cell survival, partially through downregulation of IGF1. Therefore, the miR‐497‐5p/IGF1 axis might serve as a novel therapeutic target in patients with HCC.
Databáze: OpenAIRE